CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to AMGN

Dazodalibep

Phase 3
Amgen Inc. (AMGN)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Oct '26
AMGNPhase 3

Dazodalibep Phase 3 Est. Readout

Dazodalibep
Oct 2026~
CT.gov
00%
Competitive Landscape

0 competitors in Sjögren's Syndrome (SS)

View Full Landscape
Drug Information

Target Indication

Sjögren's Syndrome (SS)

Clinical Trial

NCT06245408

Last updated: 1/7/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.